Agilysys Inc

AGYS remains in a Stage 2 uptrend with bullish medium-term momentum, but short-term price is extended into resistance under overbought conditions, suggesting deferral of execution. Preferred engagement zones are pullbacks toward the rising 9- and 20-day EMAs around the low- to mid-110s or a breakout above the 120-121 resistance on rising volume. A daily close below the 20-day EMA and 50-day SMA would invalidate this bullish posture.

• ↑Q1 FY27 revenue $87.7M (+14.3% YoY); subscription at $40.2M (+26.1%), 69.7% of recurring
• ↑FY27 revenue guidance raised to $368–373M, driven by backlog conversion
• ↓Key contracts (e.g., Marriott) drive ~majority of revenue, posing concentration risk